News from rigel pharmaceuticals, inc. A wide array of domestic and global news stories; news topics include politics / government, business, technology, religion, sports/entertainment, science/nature, and health/lifestyle. Articles that appear in this section may be written in English or other languages, as well.

Jul 08, 2009, 21:00 ET

Rigel to Host Conference Call to Discuss Results of Its Phase 2b TASKi2 Clinical Trial of R788 in Rheumatoid Arthritis

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the Company plans to host a conference call on Thursday, July 9, 2009 at 8:00 am...

Jun 10, 2009, 07:30 ET

Rigel to Present at Jefferies Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled...

Jun 01, 2009, 07:30 ET

Rigel's R788 Evaluated in Phase 2 Trial in Multiple Cancers

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that its oral Syk inhibitor, R788, is being evaluated in a Phase 2 clinical trial...

May 13, 2009, 07:30 ET

Rigel to Present at JMP Securities Research Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled...

May 05, 2009, 07:00 ET

Rigel Announces First Quarter 2009 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the first quarter ended March 31, 2009. For the first quarter of...

Mar 27, 2009, 07:30 ET

Rigel to Present at Citi's Biotech Day

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled...

Mar 13, 2009, 07:30 ET

Rigel Commences Phase 2 Trial of R788 in Peripheral T-Cell Lymphomas

Preclinical Rationale for Clinical Trial Presented at USCAP Meeting Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the enrollment of...

Mar 12, 2009, 07:30 ET

Rigel to Present at Keystone Symposia Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will be presenting at the Keystone Symposia conference on Extrinsic Control of...

Mar 06, 2009, 07:30 ET

Rigel to Present at Barclays Capital Healthcare Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Ryan Maynard, the company's vice president and chief financial officer, is...

Feb 24, 2009, 06:00 ET

Rigel Announces Fourth Quarter and Year End 2008 Financial Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for the fourth quarter and year ended December 31, 2008. For...

Feb 05, 2009, 07:30 ET

Rigel to Present at BIO CEO & Investor Conference

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower, the company's chairman and chief executive officer, is scheduled...

Feb 03, 2009, 06:00 ET

Rigel Expects R788 Partnership After Phase 2b Clinical Trials Results

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that it will delay further partnership discussions regarding R788 until after results...

Feb 02, 2009, 18:00 ET

Rigel to Host Conference Call on February 3, 2009

Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that the Company will host a conference call with simultaneous webcast on Tuesday,...

Aug 27, 2008, 01:00 ET

Rigel to Present at Thomas Weisel Partners Healthcare Conference

SOUTH SAN FRANCISCO, Calif., Aug. 27 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...

Aug 05, 2008, 01:00 ET

Rigel Announces Second Quarter 2008 Financial Results

SOUTH SAN FRANCISCO, Calif., Aug. 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today reported financial results for...

Jul 03, 2008, 01:00 ET

Rigel to Present at Collins Stewart Growth Conference

SAN FRANCISCO, July 3 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that Raul Rodriguez, Rigel's...

Jun 18, 2008, 01:00 ET

Rigel to Present at Jefferies Healthcare Conference

SOUTH SAN FRANCISCO, Calif., June 18 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...

Jun 12, 2008, 01:00 ET

Rigel Initiates Two Phase 2b Clinical Trials of R788 in Rheumatoid Arthritis

SOUTH SAN FRANCISCO, Calif., June 12 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced the initiation of two...

Jun 05, 2008, 01:00 ET

Rigel to Present at the Needham Biotechnology and Medical Technology Conference

SOUTH SAN FRANCISCO, Calif., June 5 /PRNewswire-FirstCall/ -- Rigel Pharmaceuticals, Inc. (Nasdaq: RIGL) today announced that James M. Gower,...

Jun 03, 2008, 01:00 ET

Preliminary Phase 2 Results of R788 in Lymphoma Show Benefit in Diffuse Large B-Cell and SLL/CLL

SOUTH SAN FRANCISCO, Calif., June 3 /PRNewswire-FirstCall/ -- Rigel today reported an abstract providing preliminary results of a Phase 2...